| DEAD-box RNA helicases and genome stability M Cargill, R Venkataraman, S Lee Genes 12 (10), 1471, 2021 | 73 | 2021 |
| T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab U Bughani, A Saha, A Kuriakose, R Nair, RB Sadashivarao, ... PloS one 12 (7), e0180088, 2017 | 59 | 2017 |
| Chapter 3 - Antibiotics targeting Gram-negative bacteria R Rangarajan, R Venkataraman Drug Discovery Targeting Drug-Resistant Bacteria, 39-70, 2020 | 7 | 2020 |
| Evaluation of LAMP-based assays for carbapenemase genes S Lahiri, R Venkataraman, A Jagan, G Deshmukh, S Patra, V Reddy, ... Journal of Medical Microbiology 68 (10), 1431-1437, 2019 | 7 | 2019 |
| Preparation and gene modification of nonhuman primate hematopoietic stem and progenitor cells S Radtke, AM Perez, R Venkataraman, S Reddy, KG Haworth, O Humbert, ... JoVE (Journal of Visualized Experiments), e58933, 2019 | 6 | 2019 |
| Apoptotic programs are determined during lineage commitment of CD4+ T effectors: selective regulation of T effector-memory apoptosis by inducible nitric oxide synthase D Purushothaman, N Marcel, M Garg, R Venkataraman, A Sarin The Journal of Immunology 190 (1), 97-105, 2013 | 5 | 2013 |
| Intracellular RNase activity dampens zinc finger nuclease-mediated gene editing in hematopoietic stem and progenitor cells CW Peterson, R Venkataraman, SS Reddy, D Pande, MR Enstrom, ... Molecular Therapy-Methods & Clinical Development 24, 30-39, 2022 | 4 | 2022 |
| Methods for controlling fucosylation levels in proteins P Nair, R Melarkode, R Venkataraman, L Adhikary, A Bhatnagar, ... US Patent 9,856,502, 2018 | 4 | 2018 |
| Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates S Dross, R Venkataraman, S Patel, ML Huang, CM Bollard, M Rosati, ... Frontiers in immunology 14, 1188018, 2023 | 3 | 2023 |
| Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates J Murray, T Einhaus, R Venkataraman, S Radtke, A Zhen, MA Carrillo, ... Molecular Therapy-Methods & Clinical Development 30, 276-287, 2023 | 1 | 2023 |
| Engraftment and Persistence of HDR-Edited Hematopoietic Stem and Progenitor Cells in Nonhuman Primates CW Peterson, SS Reddy, R Venkataraman, T Einhaus, O Humbert, ... MOLECULAR THERAPY 28 (4), 6-7, 2020 | 1 | 2020 |
| Methods for controlling fucosylation levels in proteins P Nair, R Melarkode, R Venkataraman, L Adhikary, A Bhatnagar, ... US Patent 10,308,970, 2019 | 1 | 2019 |
| Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab U Bughani, A Saha, A Kuriakose, R Nair, RB Sadashivarao, ... Plos one 13 (1), e0192335, 2018 | 1 | 2018 |
| Intracellular RNASE Activity Limits the Efficiency of mRNA-Based Gene Editing in Nonhuman Primate Hematopoietic Stem and Progenitor Cells CW Peterson, R Venkataraman, SS Reddy, T Einhaus, S Radtke, ... MOLECULAR THERAPY 29 (4), 105-105, 2021 | | 2021 |
| Therapeutic Antibody Secretion by Hematopoietic Stem Cells in the Non-Human Primate Model AS Kuhlmann, J Parrott, S Reddy, R Venkataraman, C Peterson, HP Kiem MOLECULAR THERAPY 28 (4), 180-181, 2020 | | 2020 |
| Vaccine-specific, ex vivo-expanded T-cell products for HIV cure CW Peterson, S Dross, R Venkataraman, L Kim, S Patel, KJ Bar, ... JOURNAL OF MEDICAL PRIMATOLOGY 48 (5), 305-305, 2019 | | 2019 |
| Metodos para controlar los niveles de fucosilacion en proteinas HV Pai, S Desan, K Shukla, S Prabhu, L Adhikary, R Venkataraman, ... | | 2016 |
